Clinical Trial Update: Lung Deposition of Beclometasone Dipropionate/Formoterol Fumarate/Glycopyrronium Bromide Administered Via pMDI in Healthy, Asthmatic and COPD Patients [Phase 1]

View source ↗

Summary

Phase 1 study evaluating lung deposition of a triple inhaled therapy (beclometasone dipropionate/formoterol fumarate/glycopyrronium bromide) delivered by a pres…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Asthma
• Chronic Obstructive Pulmonary Disease

Drugs mentioned

• Beclometasone dipropionate/formoterol fumarate/glycopyrronium bromide

Snippet

Sponsor: Chiesi Farmaceutici S.p.A. | Conditions: Chronic Obstructive Pulmonary Disease, Asthma | Phase 1 | Status: COMPLETED